Table 2

Prevalence of MetS of subjects by presence or absence of knee OA
Age (y) All Men Women
Non - OA OA P Non - OA OA P Non - OA OA P
40–49 244/945 (25.8%) 1/18 (5.6%) .056 139/434 (32.0%) 0/3 (0%) .555 105/511 (20.5%) 1/15 (6.7%) .325
50–59 190/471 (40.3%) 29/72 (40.3%) 1.000 98/253 (38.7%) 5/10 (50.0%) .520 92/218 (42.2%) 24/62 (38.7%) .663
60–69 175/355 (49.3%) 49/92 (53.3%) .559 82/202 (40.6%) 5/14 (35.7%) .786 93/153 (60.8%) 44/78 (56.4%) .572
70–79 78/157 (49.7%) 43/68 (63.2%) .080 34/76 (44.7%) 3/10 (30.0%) .504 44/81 (54.3%) 40/58 (69.0%) .113
≥80 15/36 (41.7%) 13/20 (65.0%) .162 4/14 (28.6%) 2/4 (50.0%) .569 11/22 (50.0%) 11/16 (68.8%) .326

Abbreviations: MetS metabolic syndrome, OA osteoarthritis.

Values are presented with number (%).

P-value: Chi square test or Fisher’s exact test.

Han et al.

Han et al. BMC Public Health 2013 13:603   doi:10.1186/1471-2458-13-603

Open Data